TOKYO — Japan’s government said Monday that it has agreed to purchase an antibody cocktail to be produced and marketed for COVID-19 treatment by a Japanese drug maker Chugai Pharmaceutical Co. which has a licensing deal with Roche. Chugai Pharmaceutical concluded the agreement with Roche in December for the production and marketing in Japan of the antibody cocktail for the virus treatment. Chief Cabinet Secretary Katsunobu Kato told reporters Monday that the government concluded the agreement with Chugai over the purchase of enough doses through March 2022 once the drug, now at final stages of clinical testing in Japan, is approved by the health ministry. The antibody cocktail developed by
Hence then, the article about the latest japan to purchase antibody cocktail for covid 19 was published today ( ) and is available onChron ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The Latest: Japan to purchase antibody cocktail for COVID-19 )